• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证中国老年人肌少症风险的预测模型。

Development and validation of a predictive model for the risk of sarcopenia in the older adults in China.

机构信息

School of Nursing, Jinan University, Guangzhou, Guangdong, China.

Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.

出版信息

Eur J Med Res. 2024 May 9;29(1):278. doi: 10.1186/s40001-024-01873-w.

DOI:10.1186/s40001-024-01873-w
PMID:38725036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11084063/
Abstract

BACKGROUND

Sarcopenia is a progressive age-related disease that can cause a range of adverse health outcomes in older adults, and older adults with severe sarcopenia are also at increased short-term mortality risk. The aim of this study was to construct and validate a risk prediction model for sarcopenia in Chinese older adults.

METHODS

This study used data from the 2015 China Health and Retirement Longitudinal Study (CHARLS), a high-quality micro-level data representative of households and individuals aged 45 years and older adults in China. The study analyzed 65 indicators, including sociodemographic indicators, health-related indicators, and biochemical indicators.

RESULTS

3454 older adults enrolled in the CHARLS database in 2015 were included in the final analysis. A total of 997 (28.8%) had phenotypes of sarcopenia. Multivariate logistic regression analysis showed that sex, Body Mass Index (BMI), Mean Systolic Blood Pressure (MSBP), Mean Diastolic Blood Pressure (MDBP) and pain were predictive factors for sarcopenia in older adults. These factors were used to construct a nomogram model, which showed good consistency and accuracy. The AUC value of the prediction model in the training set was 0.77 (95% CI = 0.75-0.79); the AUC value in the validation set was 0.76 (95% CI = 0.73-0.79). Hosmer-Lemeshow test values were P = 0.5041 and P = 0.2668 (both P > 0.05). Calibration curves showed significant agreement between the nomogram model and actual observations. ROC and DCA showed that the nomograms had good predictive properties.

CONCLUSIONS

The constructed sarcopenia risk prediction model, incorporating factors such as sex, BMI, MSBP, MDBP, and pain, demonstrates promising predictive capabilities. This model offers valuable insights for clinical practitioners, aiding in early screening and targeted interventions for sarcopenia in Chinese older adults.

摘要

背景

肌少症是一种与年龄相关的进行性疾病,可导致老年人出现一系列不良健康后果,严重肌少症的老年人也有更高的短期死亡风险。本研究旨在构建和验证中国老年人肌少症的风险预测模型。

方法

本研究使用了 2015 年中国健康与退休纵向研究(CHARLS)的数据,这是一项代表中国 45 岁及以上家庭和个人的高质量微观水平数据。研究分析了 65 个指标,包括社会人口统计学指标、健康相关指标和生化指标。

结果

纳入最终分析的 CHARLS 数据库 2015 年有 3454 名老年人,其中 997 名(28.8%)有肌少症表型。多变量逻辑回归分析显示,性别、体重指数(BMI)、平均收缩压(MSBP)、平均舒张压(MDBP)和疼痛是老年人肌少症的预测因素。这些因素被用来构建一个列线图模型,该模型显示了良好的一致性和准确性。在训练集中,预测模型的 AUC 值为 0.77(95%CI=0.75-0.79);在验证集中,AUC 值为 0.76(95%CI=0.73-0.79)。Hosmer-Lemeshow 检验值分别为 P=0.5041 和 P=0.2668(均 P>0.05)。校准曲线显示列线图模型与实际观察结果有显著一致性。ROC 和 DCA 显示列线图具有良好的预测性能。

结论

本研究构建的肌少症风险预测模型,纳入了性别、BMI、MSBP、MDBP 和疼痛等因素,具有良好的预测能力。该模型为临床医生提供了有价值的信息,有助于对中国老年人肌少症进行早期筛查和有针对性的干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/51894bbfcc07/40001_2024_1873_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/ba08f4254566/40001_2024_1873_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/3ea054799af8/40001_2024_1873_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/87fb0838383b/40001_2024_1873_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/0cf52bc34073/40001_2024_1873_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/50d58e091372/40001_2024_1873_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/51894bbfcc07/40001_2024_1873_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/ba08f4254566/40001_2024_1873_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/3ea054799af8/40001_2024_1873_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/87fb0838383b/40001_2024_1873_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/0cf52bc34073/40001_2024_1873_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/50d58e091372/40001_2024_1873_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a500/11084063/51894bbfcc07/40001_2024_1873_Fig6_HTML.jpg

相似文献

1
Development and validation of a predictive model for the risk of sarcopenia in the older adults in China.开发和验证中国老年人肌少症风险的预测模型。
Eur J Med Res. 2024 May 9;29(1):278. doi: 10.1186/s40001-024-01873-w.
2
Development and validation of a risk prediction model for older adults with social isolation in China.中国社会隔离老年人风险预测模型的建立与验证。
BMC Public Health. 2024 Sep 27;24(1):2600. doi: 10.1186/s12889-024-20142-3.
3
A predictive model for social participation of middle-aged and older adult stroke survivors: the China Health and Retirement Longitudinal Study.中年和老年卒中幸存者社会参与的预测模型:中国健康与养老追踪调查。
Front Public Health. 2024 Jan 12;11:1271294. doi: 10.3389/fpubh.2023.1271294. eCollection 2023.
4
Development and validation of a risk prediction model for physical frailty in older adults who are disabled.失能老年人身体虚弱风险预测模型的建立与验证
Geriatr Nurs. 2024 Jul-Aug;58:26-38. doi: 10.1016/j.gerinurse.2024.04.020. Epub 2024 May 10.
5
Development and validation of a nomogram to predict the depressive symptoms among older adults: A national survey in China.开发和验证预测中国老年人抑郁症状的列线图:一项全国性调查。
J Affect Disord. 2024 Sep 15;361:367-375. doi: 10.1016/j.jad.2024.06.036. Epub 2024 Jun 17.
6
A nomogram to predict the risk of sarcopenia in older people.用于预测老年人肌少症风险的列线图。
Medicine (Baltimore). 2023 Apr 21;102(16):e33581. doi: 10.1097/MD.0000000000033581.
7
Development and Validation of a Nomogram for Predicting Sarcopenia in Community-Dwelling Older Adults.用于预测社区居住老年人肌肉减少症的列线图的开发与验证
J Am Med Dir Assoc. 2022 May;23(5):715-721.e5. doi: 10.1016/j.jamda.2021.11.023. Epub 2021 Dec 20.
8
Development and validation of a risk prediction model for motoric cognitive risk syndrome in older adults.老年人运动认知风险综合征风险预测模型的建立与验证。
Aging Clin Exp Res. 2024 Jul 13;36(1):143. doi: 10.1007/s40520-024-02797-5.
9
Development and validation of a predictive model assessing the risk of sarcopenia in rheumatoid arthritis patients.评估类风湿关节炎患者肌少症风险的预测模型的建立和验证。
Front Immunol. 2024 Jul 29;15:1437980. doi: 10.3389/fimmu.2024.1437980. eCollection 2024.
10
A nomogram for screening sarcopenia in Chinese type 2 diabetes mellitus patients.用于筛查中国 2 型糖尿病患者肌肉减少症的列线图。
Exp Gerontol. 2023 Feb;172:112069. doi: 10.1016/j.exger.2022.112069. Epub 2022 Dec 16.

引用本文的文献

1
A nomogram to predict sarcopenia in older adults: a multi-center study in rural China.预测老年人肌少症的列线图:中国农村地区的一项多中心研究。
BMC Geriatr. 2025 Jul 10;25(1):513. doi: 10.1186/s12877-025-06163-6.
2
Sarcopenia is associated with increased hip fracture risk among middle-aged and elderly Chinese adults in longitudinal analysis of CHARLS data.在中国健康与养老追踪调查(CHARLS)数据的纵向分析中,肌肉减少症与中国中老年人髋部骨折风险增加有关。
Sci Rep. 2025 Jul 9;15(1):24598. doi: 10.1038/s41598-025-10341-2.
3
Risk Factors and Predictive Models for Sarcopenia in Older Adults.

本文引用的文献

1
Sarcopenia and Chronic Pain in the Elderly: A Systematic Review and Meta-Analysis.老年人的肌肉减少症与慢性疼痛:一项系统评价和荟萃分析。
J Pain Res. 2023 Oct 26;16:3569-3581. doi: 10.2147/JPR.S435866. eCollection 2023.
2
Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Older Adults with Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Study.β-羟-β-甲基丁酸补充剂对肌少症老年人的影响:一项随机、双盲、安慰剂对照研究。
J Nutr Health Aging. 2023;27(5):329-339. doi: 10.1007/s12603-023-1911-1.
3
Sarcopenia and Cardiovascular Diseases.
老年人肌肉减少症的风险因素及预测模型
Aging Med (Milton). 2025 Apr 18;8(3):192-199. doi: 10.1002/agm2.70012. eCollection 2025 Jun.
4
Development and validation of a predictive model for sarcopenia risk in older Chinese adults based on key factors.基于关键因素的中国老年人群肌肉减少症风险预测模型的开发与验证
BMC Geriatr. 2025 Jul 2;25(1):464. doi: 10.1186/s12877-025-06104-3.
5
Risk prediction models for sarcopenia in elderly people: a systematic review and meta-analysis.老年人肌肉减少症的风险预测模型:一项系统评价和荟萃分析。
Front Med (Lausanne). 2025 Jun 2;12:1589583. doi: 10.3389/fmed.2025.1589583. eCollection 2025.
6
Muscle elasticity variations in assessing age-related changes in adults - A systematic review.评估成年人年龄相关变化时的肌肉弹性变化——一项系统综述
Geriatr Gerontol Int. 2025 Jul;25(7):855-863. doi: 10.1111/ggi.70073. Epub 2025 Jun 11.
7
Development and validation of a predictive model for the risk of possible sarcopenia in middle-aged and older adult diabetes mellitus in China.中国中老年糖尿病患者潜在肌肉减少症风险预测模型的建立与验证
Front Public Health. 2025 Apr 3;13:1521736. doi: 10.3389/fpubh.2025.1521736. eCollection 2025.
8
Predictive model for sarcopenia in chronic kidney disease: a nomogram and machine learning approach using CHARLS data.慢性肾脏病肌少症的预测模型:基于中国健康与养老追踪调查(CHARLS)数据的列线图和机器学习方法
Front Med (Lausanne). 2025 Mar 12;12:1546988. doi: 10.3389/fmed.2025.1546988. eCollection 2025.
9
An explainable machine learning-based prediction model for sarcopenia in elderly Chinese people with knee osteoarthritis.一种基于可解释机器学习的中国老年膝骨关节炎患者肌肉减少症预测模型。
Aging Clin Exp Res. 2025 Mar 7;37(1):67. doi: 10.1007/s40520-025-02931-x.
10
Development and Validation of a Risk Prediction Model for Sarcopenia in Chinese Older Patients with Type 2 Diabetes Mellitus.中国老年 2 型糖尿病患者肌少症风险预测模型的开发与验证
Diabetes Metab Syndr Obes. 2024 Nov 30;17:4611-4626. doi: 10.2147/DMSO.S493903. eCollection 2024.
肌肉减少症与心血管疾病
Circulation. 2023 May 16;147(20):1534-1553. doi: 10.1161/CIRCULATIONAHA.123.064071. Epub 2023 May 15.
4
A nomogram to predict the risk of sarcopenia in older people.用于预测老年人肌少症风险的列线图。
Medicine (Baltimore). 2023 Apr 21;102(16):e33581. doi: 10.1097/MD.0000000000033581.
5
Development of a risk prediction nomogram for sarcopenia in hemodialysis patients.开发一种用于血液透析患者肌少症的风险预测列线图。
BMC Nephrol. 2022 Sep 23;23(1):319. doi: 10.1186/s12882-022-02942-0.
6
Blood Flow Restriction Training for the Intervention of Sarcopenia: Current Stage and Future Perspective.用于干预肌肉减少症的血流限制训练:现状与未来展望
Front Med (Lausanne). 2022 Jun 13;9:894996. doi: 10.3389/fmed.2022.894996. eCollection 2022.
7
The China Alzheimer Report 2022.《2022年中国阿尔茨海默病报告》
Gen Psychiatr. 2022 Mar 11;35(1):e100751. doi: 10.1136/gpsych-2022-100751. eCollection 2022.
8
Prevalence of Sarcopenia in Pain Patients and Correlation Between the Two Conditions: A Systematic Review and Meta-Analysis.疼痛患者中肌肉减少症的患病率及其与疼痛的相关性:一项系统评价和荟萃分析
J Am Med Dir Assoc. 2022 May;23(5):902.e1-902.e20. doi: 10.1016/j.jamda.2022.02.005. Epub 2022 Mar 23.
9
Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study.中老年人群中肌肉减少症与心血管疾病的关联:来自中国健康与养老追踪调查的结果
EClinicalMedicine. 2022 Jan 10;44:101264. doi: 10.1016/j.eclinm.2021.101264. eCollection 2022 Feb.
10
Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.社区居住老年人肌少症的相关因素:系统评价和荟萃分析。
Nutrients. 2021 Nov 27;13(12):4291. doi: 10.3390/nu13124291.